AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 143 filers reported holding AVIDITY BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,708,130 | +15.1% | 267,732 | +100.0% | 0.00% | 0.0% |
| Q2 2023 | $1,484,574 | -36.6% | 133,866 | -12.3% | 0.00% | -33.3% |
| Q1 2023 | $2,341,919 | -35.8% | 152,568 | -7.2% | 0.00% | -40.0% |
| Q4 2022 | $3,648,369 | +63.8% | 164,415 | +23.4% | 0.01% | +66.7% |
| Q3 2022 | $2,228,000 | +15.7% | 133,271 | +0.6% | 0.00% | +50.0% |
| Q2 2022 | $1,925,000 | -27.2% | 132,471 | -7.4% | 0.00% | 0.0% |
| Q1 2022 | $2,643,000 | -25.0% | 143,086 | -3.5% | 0.00% | -33.3% |
| Q4 2021 | $3,526,000 | +38.2% | 148,344 | +43.2% | 0.00% | 0.0% |
| Q3 2021 | $2,551,000 | +372.4% | 103,575 | +270.6% | 0.00% | +200.0% |
| Q2 2021 | $540,000 | -11.5% | 27,948 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $610,000 | +3.0% | 27,948 | +20.4% | 0.00% | 0.0% |
| Q4 2020 | $592,000 | -2.6% | 23,209 | +7.4% | 0.00% | 0.0% |
| Q3 2020 | $608,000 | +5.9% | 21,609 | +6.4% | 0.00% | 0.0% |
| Q2 2020 | $574,000 | – | 20,309 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 849,651 | $13,042,143 | 13.77% |
| COWEN AND COMPANY, LLC | 4,592,966 | $70,502,028 | 8.28% |
| Cormorant Asset Management, LP | 2,612,115 | $40,096 | 2.64% |
| 5AM Venture Management, LLC | 665,555 | $10,216,269 | 2.61% |
| RA Capital Management | 6,416,998 | $98,500,919 | 2.23% |
| RTW INVESTMENTS, LP | 6,387,178 | $98,043,182 | 2.04% |
| COMMODORE CAPITAL LP | 590,705 | $9,067,322 | 1.38% |
| Casdin Capital, LLC | 850,000 | $13,047,500 | 1.08% |
| Boxer Capital, LLC | 1,121,327 | $17,212 | 0.85% |
| Octagon Capital Advisors LP | 382,000 | $5,863,700 | 0.84% |